|
Apoptosis
Citations 361-370 of 746 total displayed.
|
Past content
(since May 2000):
|
The FIP1L1-PDGFR fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management
- Jason Gotlib, Jan Cools, James M. Malone, III, Stanley L. Schrier, D. Gary Gilliland, and Steven E. Coutré
Blood 2004; 103: 2879-2891.
[Abstract]
[Full text]
[PDF]
Gas1 is induced by VE-cadherin and vascular endothelial growth factor and inhibits endothelial cell apoptosis
- Raffaella Spagnuolo, Monica Corada, Fabrizio Orsenigo, Lucia Zanetta, Ulrich Deuschle, Peter Sandy, Claudio Schneider, Christopher J. Drake, Ferruccio Breviario, and Elisabetta Dejana
Blood 2004; 103: 3005-3012.
[Abstract]
[Full text]
[PDF]
The quantity and duration of FcR signals determine mast cell degranulation and survival
- Sho Yamasaki, Eri Ishikawa, Masayuki Kohno, and Takashi Saito
Blood 2004; 103: 3093-3101.
[Abstract]
[Full text]
[PDF]
Do thymically and strictly extrathymically developing T cells generate similar immune responses?
- Marie-Ève Blais, Gwladys Gérard, Marianne M. Martinic, Guillaume Roy-Proulx, Rolf M. Zinkernagel, and Claude Perreault
Blood 2004; 103: 3102-3110.
[Abstract]
[Full text]
[PDF]
Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone
- Thomas Strömberg, Anna Dimberg, Anna Hammarberg, Kristina Carlson, Anders Österborg, Kenneth Nilsson, and Helena Jernberg-Wiklund
Blood 2004; 103: 3138-3147.
[Abstract]
[Full text]
[PDF]
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
- Jérôme Moreaux, Eric Legouffe, Eric Jourdan, Philippe Quittet, Thierry Rème, Cécile Lugagne, Philippe Moine, Jean-François Rossi, Bernard Klein, and Karin Tarte
Blood 2004; 103: 3148-3157.
[Abstract]
[Full text]
[PDF]
The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti–multiple myeloma (MM) activity and overcome bortezomib resistance
- Dharminder Chauhan, Guilan Li, Klaus Podar, Teru Hideshima, Reshma Shringarpure, Laurence Catley, Constantine Mitsiades, Nikhil Munshi, Yu Tzu Tai, Nanjoo Suh, Gordon W. Gribble, Tadashi Honda, Robert Schlossman, Paul Richardson, Michael B. Sporn, and Kenneth C. Anderson
Blood 2004; 103: 3158-3166.
[Abstract]
[Full text]
[PDF]
Nuclear factor– B and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis
- Alok C. Bharti, Shishir Shishodia, James M. Reuben, Donna Weber, Raymond Alexanian, Saroj Raj-Vadhan, Zeev Estrov, Moshe Talpaz, and Bharat B. Aggarwal
Blood 2004; 103: 3175-3184.
[Abstract]
[Full text]
[PDF]
Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein
- Takayuki Matsunaga, Toshiya Inaba, Hirotaka Matsui, Mayuko Okuya, Atsushi Miyajima, Takeshi Inukai, Tetsunori Funabiki, Mikiya Endo, A. Thomas Look, and Hidemitsu Kurosawa
Blood 2004; 103: 3185-3191.
[Abstract]
[Full text]
[PDF]
Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells
- Ira Jakupovic, Victoria L. Grandage, David C. Linch, and Asim Khwaja
Blood 2004; 103: 3230-3232.
[Abstract]
[Full text]
[PDF]
|
|
